you are here: Home News Us Fda

Us Fda

FDA recalls Friendly’s and Blue Bell ice cream over undeclared allergens: What you need to know
Is orange juice too sweet for your health? US FDA plans to cut sugar as experts urge caution
Stocks To Watch: Alembic Pharma, BHEL, Zydus Life, Wipro In Focus | February 17
Stocks On Radar: Lupin, Hero MotoCorp, Eicher Motors, MOIL In Focus | February 3
Dr Reddy's: US FDA issues form 483 with 4 observations for its Andhra facility
Lupin stock climbs nearly 4% on launch of Mirabegron Extended-Release tablets in US
US FDA releases details of OAI observations at Sun Pharma’s Dadra plant
US FDA releases details of observations on Alkem's Baddi Plant
Lupin, Glenmark, Natco recall products from US markets
US FDA issues 4 observations for Zydus Life's Ahmedabad injectable plant
Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility
US FDA makes observation on Lupin's Aurangabad plant
US FDA delays Lilly Alzheimer's drug decision, calls for advisory panel
US FDA slaps Aurobindo Pharma's Telangana injectable facility with 7 observations
Pfizer, Glenmark join hands to launch skin disease drug in India
US FDA releases detailed observations at Torrent's Chhatral unit; shares trade high
A year of hits and misses for the Indian pharma sector
Aurobindo subsidiary in Tirupati classified as VAI by US FDA
US FDA inspects Dr. Reddy's, Sun Pharma, Torrent Pharma, Laurus Labs plants
US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant
Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA
Lupin gets approval from US FDA for Ganirelix Acetate injection
USFDA flags cleanliness, procedural issues at Dr Reddy's Bachupally unit in Hyderabad
IPCA Pithampur unit in minimally acceptable state of compliance by US FDA
Dr. Reddy’s Hyderabad plant handed 10 US FDA observations

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Us Fda

FDA recalls Friendly’s and Blue Bell ice cream over undeclared allergens: What you need to know

Is orange juice too sweet for your health? US FDA plans to cut sugar as experts urge caution

Stocks To Watch: Alembic Pharma, BHEL, Zydus Life, Wipro In Focus | February 17

Stocks On Radar: Lupin, Hero MotoCorp, Eicher Motors, MOIL In Focus | February 3

Dr Reddy's: US FDA issues form 483 with 4 observations for its Andhra facility

Lupin stock climbs nearly 4% on launch of Mirabegron Extended-Release tablets in US

US FDA releases details of OAI observations at Sun Pharma’s Dadra plant

US FDA releases details of observations on Alkem's Baddi Plant

Lupin, Glenmark, Natco recall products from US markets

US FDA issues 4 observations for Zydus Life's Ahmedabad injectable plant

Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility

US FDA makes observation on Lupin's Aurangabad plant

US FDA delays Lilly Alzheimer's drug decision, calls for advisory panel

US FDA slaps Aurobindo Pharma's Telangana injectable facility with 7 observations

Pfizer, Glenmark join hands to launch skin disease drug in India

US FDA releases detailed observations at Torrent's Chhatral unit; shares trade high

A year of hits and misses for the Indian pharma sector

Aurobindo subsidiary in Tirupati classified as VAI by US FDA

US FDA inspects Dr. Reddy's, Sun Pharma, Torrent Pharma, Laurus Labs plants

US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant

Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

Lupin gets approval from US FDA for Ganirelix Acetate injection

USFDA flags cleanliness, procedural issues at Dr Reddy's Bachupally unit in Hyderabad

IPCA Pithampur unit in minimally acceptable state of compliance by US FDA

Dr. Reddy’s Hyderabad plant handed 10 US FDA observations